Tuberculose e COVID-19, o novo dueto maldito: quais as diferenças entre Brasil e Europa?
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2021 |
| Outros Autores: | , , , , |
| Tipo de documento: | Artigo |
| Idioma: | por |
| Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
| Texto Completo: | https://www.arca.fiocruz.br/handle/icict/52583 |
Resumo: | Em 1º de abril de 2020, a COVID-19 ultrapassou a tuberculose em número de óbitos por dia no mundo. A associação da tuberculose com a COVID-19 apresenta grande potencial de morbidade e mortalidade. Além disso, a pandemia de COVID-19 tem tido um impacto significativo no diagnóstico e tratamento da tuberculose. Neste artigo de revisão, abordamos tuberculose e COVID-19 concomitantes, com particular atenção às diferenças entre Brasil e Europa. Além disso, discutimos as prioridades em atendimento clínico, saúde pública e pesquisa. |
| id |
CRUZ_689dd00077ed61d41dbdd3b6d4e0f791 |
|---|---|
| oai_identifier_str |
oai:www.arca.fiocruz.br:icict/52583 |
| network_acronym_str |
CRUZ |
| network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| repository_id_str |
2135 |
| spelling |
Silva, Denise RossatoMello, Fernanda Carvalho de QueirozD’Ambrosio, LiaCentis, RosellaDalcolmo, Margareth PrettiBattista Migliori, Giovanni2022-05-08T23:55:10Z2022-05-08T23:55:10Z2021SILVA, Denise Rossato et al. Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe? Jornal Brasileiro de Pneumologia, v. 47, n. 2, p. 1-8, 2021.1806-3756https://www.arca.fiocruz.br/handle/icict/5258310.36416/1806-3756/e20210044Em 1º de abril de 2020, a COVID-19 ultrapassou a tuberculose em número de óbitos por dia no mundo. A associação da tuberculose com a COVID-19 apresenta grande potencial de morbidade e mortalidade. Além disso, a pandemia de COVID-19 tem tido um impacto significativo no diagnóstico e tratamento da tuberculose. Neste artigo de revisão, abordamos tuberculose e COVID-19 concomitantes, com particular atenção às diferenças entre Brasil e Europa. Além disso, discutimos as prioridades em atendimento clínico, saúde pública e pesquisa.On April 1st, 2020, COVID-19 surpassed tuberculosis regarding the number of deaths per day worldwide. The combination of tuberculosis and COVID-19 has great potential for morbidity and mortality. In addition, the COVID-19 pandemic has had a significant impact on the diagnosis and treatment of tuberculosis. In this review article, we address concurrent tuberculosis and COVID-19, with particular regard to the differences between Brazil and Europe. In addition, we discuss priorities in clinical care, public health, and research.Universidade Federal do Rio Grande do Sul. Faculdade de Medicina. Porto Alegre, RS, Brasil.Universidade Federal do Rio de Janeiro. Faculdade de Medicina. Instituto de Doenças do Tórax. Rio de Janeiro, RJ, Brasil.Istituti Clinici Scientifici Maugeri. Servizio di Epidemiologia Clinica delle Malattie Respiratorie. Tradate, Italia.Queen Mary University of London. Blizard Institute. London, United Kingdom.Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Centro de Referência Hélio Fraga. Rio de Janeiro, RJ, Brasil.Istituti Clinici Scientifici Maugeri. Servizio di Epidemiologia Clinica delle Malattie Respiratorie. Tradate, Italia / Queen Mary University of London. Blizard Institute. London, United Kingdom.porSociedade Brasileira de Pneumologia e TisiologiaTuberculoseInfecções por coronavirusBetacoronavirusCoronavirusCOVID-19SARS-CoV-2TuberculosisCoronavirus of InfectionsBetacoronavirusCoronavirus.COVID-19SARS-CoV-2Tuberculose e COVID-19, o novo dueto maldito: quais as diferenças entre Brasil e Europa?Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83134https://www.arca.fiocruz.br/bitstream/icict/52583/1/license.txt0ab46789d568c4ba27c7b5d29a9fe9c4MD51ORIGINALSilva_Denise_etal_ENSP_COVID-19_2021_VERSÃO_PORTUGUÊS.pdfSilva_Denise_etal_ENSP_COVID-19_2021_VERSÃO_PORTUGUÊS.pdfapplication/pdf667813https://www.arca.fiocruz.br/bitstream/icict/52583/2/Silva_Denise_etal_ENSP_COVID-19_2021_VERS%c3%83O_PORTUGU%c3%8aS.pdf75b549790f70501aa2e02988800b980aMD52Silva_Denise_etal_ENSP_COVID-19_2021_VERSÃO_INGLÊS.pdfSilva_Denise_etal_ENSP_COVID-19_2021_VERSÃO_INGLÊS.pdfapplication/pdf630833https://www.arca.fiocruz.br/bitstream/icict/52583/3/Silva_Denise_etal_ENSP_COVID-19_2021_VERS%c3%83O_INGL%c3%8aS.pdf916ee6a8b18355862e2cd37b9092feb1MD53icict/525832022-05-08 20:56:06.477oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352022-05-08T23:56:06Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
| dc.title.pt_BR.fl_str_mv |
Tuberculose e COVID-19, o novo dueto maldito: quais as diferenças entre Brasil e Europa? |
| dc.title.alternative.pt_BR.fl_str_mv |
Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe? |
| title |
Tuberculose e COVID-19, o novo dueto maldito: quais as diferenças entre Brasil e Europa? |
| spellingShingle |
Tuberculose e COVID-19, o novo dueto maldito: quais as diferenças entre Brasil e Europa? Silva, Denise Rossato Tuberculose Infecções por coronavirus Betacoronavirus Coronavirus COVID-19 SARS-CoV-2 Tuberculosis Coronavirus of Infections Betacoronavirus Coronavirus. COVID-19 SARS-CoV-2 |
| title_short |
Tuberculose e COVID-19, o novo dueto maldito: quais as diferenças entre Brasil e Europa? |
| title_full |
Tuberculose e COVID-19, o novo dueto maldito: quais as diferenças entre Brasil e Europa? |
| title_fullStr |
Tuberculose e COVID-19, o novo dueto maldito: quais as diferenças entre Brasil e Europa? |
| title_full_unstemmed |
Tuberculose e COVID-19, o novo dueto maldito: quais as diferenças entre Brasil e Europa? |
| title_sort |
Tuberculose e COVID-19, o novo dueto maldito: quais as diferenças entre Brasil e Europa? |
| author |
Silva, Denise Rossato |
| author_facet |
Silva, Denise Rossato Mello, Fernanda Carvalho de Queiroz D’Ambrosio, Lia Centis, Rosella Dalcolmo, Margareth Pretti Battista Migliori, Giovanni |
| author_role |
author |
| author2 |
Mello, Fernanda Carvalho de Queiroz D’Ambrosio, Lia Centis, Rosella Dalcolmo, Margareth Pretti Battista Migliori, Giovanni |
| author2_role |
author author author author author |
| dc.contributor.author.fl_str_mv |
Silva, Denise Rossato Mello, Fernanda Carvalho de Queiroz D’Ambrosio, Lia Centis, Rosella Dalcolmo, Margareth Pretti Battista Migliori, Giovanni |
| dc.subject.other.pt_BR.fl_str_mv |
Tuberculose Infecções por coronavirus Betacoronavirus Coronavirus COVID-19 SARS-CoV-2 |
| topic |
Tuberculose Infecções por coronavirus Betacoronavirus Coronavirus COVID-19 SARS-CoV-2 Tuberculosis Coronavirus of Infections Betacoronavirus Coronavirus. COVID-19 SARS-CoV-2 |
| dc.subject.en.pt_BR.fl_str_mv |
Tuberculosis Coronavirus of Infections Betacoronavirus Coronavirus. COVID-19 SARS-CoV-2 |
| description |
Em 1º de abril de 2020, a COVID-19 ultrapassou a tuberculose em número de óbitos por dia no mundo. A associação da tuberculose com a COVID-19 apresenta grande potencial de morbidade e mortalidade. Além disso, a pandemia de COVID-19 tem tido um impacto significativo no diagnóstico e tratamento da tuberculose. Neste artigo de revisão, abordamos tuberculose e COVID-19 concomitantes, com particular atenção às diferenças entre Brasil e Europa. Além disso, discutimos as prioridades em atendimento clínico, saúde pública e pesquisa. |
| publishDate |
2021 |
| dc.date.issued.fl_str_mv |
2021 |
| dc.date.accessioned.fl_str_mv |
2022-05-08T23:55:10Z |
| dc.date.available.fl_str_mv |
2022-05-08T23:55:10Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
SILVA, Denise Rossato et al. Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe? Jornal Brasileiro de Pneumologia, v. 47, n. 2, p. 1-8, 2021. |
| dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/52583 |
| dc.identifier.issn.pt_BR.fl_str_mv |
1806-3756 |
| dc.identifier.doi.none.fl_str_mv |
10.36416/1806-3756/e20210044 |
| identifier_str_mv |
SILVA, Denise Rossato et al. Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe? Jornal Brasileiro de Pneumologia, v. 47, n. 2, p. 1-8, 2021. 1806-3756 10.36416/1806-3756/e20210044 |
| url |
https://www.arca.fiocruz.br/handle/icict/52583 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Pneumologia e Tisiologia |
| publisher.none.fl_str_mv |
Sociedade Brasileira de Pneumologia e Tisiologia |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
| instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
| instacron_str |
FIOCRUZ |
| institution |
FIOCRUZ |
| reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| collection |
Repositório Institucional da FIOCRUZ (ARCA) |
| bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/52583/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/52583/2/Silva_Denise_etal_ENSP_COVID-19_2021_VERS%c3%83O_PORTUGU%c3%8aS.pdf https://www.arca.fiocruz.br/bitstream/icict/52583/3/Silva_Denise_etal_ENSP_COVID-19_2021_VERS%c3%83O_INGL%c3%8aS.pdf |
| bitstream.checksum.fl_str_mv |
0ab46789d568c4ba27c7b5d29a9fe9c4 75b549790f70501aa2e02988800b980a 916ee6a8b18355862e2cd37b9092feb1 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
| repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
| _version_ |
1813009040192569344 |